Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance

by Daniel J. Crona, Young E. Whang
Published 2017-06-01

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients

by Jing Zhu, Olivia Campagne, Chad D. Torrice, Gabrielle Flynn, Jordan A. Miller, Tejendra Patel, Oscar Suzuki, Jonathan R. Ptachcinski, Paul M. Armistead, Tim Wiltshire, Donald E. Mager, Daniel L. Weiner, Daniel J. Crona
Published 2021-05-01

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

by Stephanie I Kim, Andy H Szeto, Katherine P Morgan, Blaine Brower, Mary W Dunn, Amir H Khandani, Paul A Godley, Tracy L Rose, Ethan M Basch, Matthew I Milowsky, Young E Whang, Daniel J Crona
Published 2021-01-01

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients

by Jing Zhu, Tejendra Patel, Jordan A. Miller, Chad D. Torrice, Mehak Aggarwal, Margaret R. Sketch, Maurice D. Alexander, Paul M. Armistead, James M. Coghill, Tatjana Grgic, Katarzyna J. Jamieson, Jonathan R. Ptachcinski, Marcie L. Riches, Jonathan S. Serody, John L. Schmitz, J. Ryan Shaw, Thomas C. Shea, Oscar Suzuki, Benjamin G. Vincent, William A. Wood, Kamakshi V. Rao, Tim Wiltshire, Eric T. Weimer, Daniel J. Crona
Published 2020-01-01